RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Asahi Kasei
A

Asahi Kasei portfolio

Asahi Kasei has 4 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 4.
Deals, last 12 months: 0.
Capital in their rounds: $119M.
Latest deal: Noctrix Health · Jan 16, 2024.
About this page

Its most recent investment on record is Noctrix Health's $40M Series B+ round in January 2024, alongside Angelini Ventures, Treo Ventures, OrbiMed and 2 others. By category, its portfolio leans toward Health and bio (2) and Legal and compliance (1). It has co-invested with Angelini Ventures, OrbiMed and Sectoral Asset Management.

What Asahi Kasei invests in

Asahi Kasei recent investments

CompanyRoundDateAlongside
NNoctrix HealthSeries B+ · $40MAngelini Ventures, Treo Ventures, OrbiMed +2
CCirculariseSeries A · $11MNeste, Brightlands Venture Partners (lead), 4impact
GGlycomineSeries B+ · $68MRiverVest, Novo Holdings, Abingworth (lead) +5

How Asahi Kasei invests

StageDealsCapital in rounds
Series B+ 2 67%$108M
Series A 1 33%$11M
YearDealsCapital in rounds
2021 1 33%$68M
2022 1 33%$11M
2024 1 33%$40M

Asahi Kasei portfolio companies

CompanyRound with Asahi KaseiTotal raisedLatest raise
NNoctrix Health
Health and bio
Series B+ · $40M$73.5MSep 2, 2025
round
CCircularise
Legal and compliance
Series A · $11M$11MApr 19, 2025
Series A
GGlycomine
Health and bio
Series B+ · $68M$195MMay 9, 2025
Series B+
MMangrove Lithium
Climate and energy
backer$95MJan 15, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 3 rounds on Recent Funding that name Asahi Kasei. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Asahi Kasei, which is a subset of its real portfolio. API: /api/v1/investors/asahi-kasei (get a free API key). More: the most active VC firms and new venture capital funds.